(E)-S-(1-butenyl) cysteine S-oxide

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: (E)-S-(1-butenyl) cysteine S-oxide
• 英文别名: (2R)-2-azaniumyl-3-[(E)-but-1-enyl]sulfinylpropanoate
• 化学式: C7H13NO3S
• 分子量: 191.25
• InChiKey: SNXJMSVHWSIWAN-DAWATQQYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -2.4
• 重原子数：
  12
• 可旋转键数：
  4
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.57
• 拓扑面积：
  104
• 氢给体数：
  1
• 氢受体数：
  4

文献信息

• S-METHYLCYSTEINE SULFOXIDE FOR PROSTATE CANCER PREVENTION AND TREATMENT
  申请人：Quadram Institute Bioscience

  公开号：EP3432876A1

  公开（公告）日：2019-01-30
• [EN] S-METHYLCYSTEINE SULFOXIDE FOR PROSTATE CANCER PREVENTION AND TREATMENT<br/>[FR] S-MÉTHYLCYSTÉINE SULFOXYDE SERVANT À LA PRÉVENTION ET LE TRAITEMENT DU CANCER DE LA PROSTATE
  申请人：THE INST OF FOOD RES

  公开号：WO2017163081A1

  公开（公告）日：2017-09-28

  The present invention relates to S-methylcysteine sulfoxide and compositions thereof for use in the treatment or prevention of prostate cancer. It also relates to analogues, derivatives or metabolites of S-methylcysteine sulfoxide for use in the treatment or prevention of prostate cancer. Compositions of S-methylcysteine sulfoxide or its analogues, derivatives or metabolites may be provided for oral consumption, for example as a pharmaceutical composition, a medicament or a food composition.